Skip to main content
Top
Published in: Journal of Gastrointestinal Cancer 3/2012

01-09-2012 | Brief Communication

Vitamin D Receptor Gene Variants and Esophageal Adenocarcinoma Risk: A Population-Based Case–Control Study

Authors: C. K. Chang, H. G. Mulholland, M. M. Cantwell, L. A. Anderson, B. T. Johnston, A. J. McKnight, P. D. Thompson, R. G. P. Watson, L. J. Murray, on behalf of the FINBAR study group

Published in: Journal of Gastrointestinal Cancer | Issue 3/2012

Login to get access

Abstract

Purpose

Polymorphisms in the vitamin D receptor (VDR) gene may be of etiological importance in determining cancer risk. The aim of this study was to assess the association between common VDR gene polymorphisms and esophageal adenocarcinoma (EAC) risk in an all-Ireland population-based case–control study.

Methods

EAC cases and frequency-matched controls by age and gender recruited between March 2002 and December 2004 throughout Ireland were included. Participants were interviewed, and a blood sample collected for DNA extraction. Twenty-seven single nucleotide polymorphisms in the VDR gene were genotyped using Sequenom or TaqMan assays while the poly(A) microsatellite was genotyped by fluorescent fragment analysis. Unconditional logistic regression was applied to assess the association between VDR polymorphisms and EAC risk.

Results

A total of 224 cases of EAC and 256 controls were involved in analyses. After adjustment for potential confounders, TT homozygotes at rs2238139 and rs2107301 had significantly reduced risks of EAC compared with CC homozygotes. In contrast, SS alleles of the poly(A) microsatellite had significantly elevated risks of EAC compared with SL/LL alleles. However, following permutation analyses to adjust for multiple comparisons, no significant associations were observed between any VDR gene polymorphism and EAC risk.

Conclusions

VDR gene polymorphisms were not significantly associated with EAC development in this Irish population. Confirmation is required from larger studies.
Literature
1.
go back to reference Dusso AS, Brown AJ, Slatopolsky E. Vitamin D. Am J Renal Physiol. 2005;289:F8–28.CrossRef Dusso AS, Brown AJ, Slatopolsky E. Vitamin D. Am J Renal Physiol. 2005;289:F8–28.CrossRef
2.
go back to reference Ebert R, Schutze N, Adamski J, Jakob F. Vitamin D signalling is modulated on multiple levels in health and disease. Mol Cell Endocrinol. 2006;248:149–59.PubMedCrossRef Ebert R, Schutze N, Adamski J, Jakob F. Vitamin D signalling is modulated on multiple levels in health and disease. Mol Cell Endocrinol. 2006;248:149–59.PubMedCrossRef
3.
go back to reference Anderson PH, May BK, Morris HA. Vitamin D metabolism: new concepts and clinical implications. Clin Biochem Rev. 2003;24:13–26.PubMed Anderson PH, May BK, Morris HA. Vitamin D metabolism: new concepts and clinical implications. Clin Biochem Rev. 2003;24:13–26.PubMed
4.
go back to reference Lowe LC, Guy M, Mansi JL, et al. Plasma 25-hydroxy vitamin D concentrations, vitamin D receptor genotype and breast cancer risk in a UK Caucasian population. Eur J Cancer. 2005;41:1164–9.PubMedCrossRef Lowe LC, Guy M, Mansi JL, et al. Plasma 25-hydroxy vitamin D concentrations, vitamin D receptor genotype and breast cancer risk in a UK Caucasian population. Eur J Cancer. 2005;41:1164–9.PubMedCrossRef
5.
go back to reference Holick CN, Stanford JL, Kwon EM, et al. Comprehensive association analysis of the vitamin D pathway genes, VDR, CYP27B1 and CYP24A1, in prostate cancer. Cancer Epidemiol Biomarkers Prev. 2007;16:1990–9.PubMedCrossRef Holick CN, Stanford JL, Kwon EM, et al. Comprehensive association analysis of the vitamin D pathway genes, VDR, CYP27B1 and CYP24A1, in prostate cancer. Cancer Epidemiol Biomarkers Prev. 2007;16:1990–9.PubMedCrossRef
6.
go back to reference Pera M, Manterola C, Vidal O, et al. Epidemiology of esophageal adenocarcinoma. J Surg Oncol. 2005;92:151–9.PubMedCrossRef Pera M, Manterola C, Vidal O, et al. Epidemiology of esophageal adenocarcinoma. J Surg Oncol. 2005;92:151–9.PubMedCrossRef
7.
go back to reference De Gottardi A, Dumonceau JM, Bruttin F, et al. Expression of the bile acid receptor FXR in Barrett’s esophagus and enhancement of apoptosis by guggulsterone in vitro. Mol Cancer. 2006;5:48–58.PubMedCrossRef De Gottardi A, Dumonceau JM, Bruttin F, et al. Expression of the bile acid receptor FXR in Barrett’s esophagus and enhancement of apoptosis by guggulsterone in vitro. Mol Cancer. 2006;5:48–58.PubMedCrossRef
8.
go back to reference Anderson LA, Johnston BT, Watson RG, et al. Nonsteroidal anti-inflammatory drugs and the esophageal inflammation-metaplasia-adenocarcinoma sequence. Cancer Res. 2006;66:4975–82.PubMedCrossRef Anderson LA, Johnston BT, Watson RG, et al. Nonsteroidal anti-inflammatory drugs and the esophageal inflammation-metaplasia-adenocarcinoma sequence. Cancer Res. 2006;66:4975–82.PubMedCrossRef
9.
go back to reference Mulholland HG, Cantwell MM, Anderson LA, et al. Glycemic index, carbohydrate and fiber intakes and risk of reflux esophagitis, Barrett’s esophagus, and esophageal adenocarcinoma. Cancer Causes Control. 2009;20:279–88.PubMedCrossRef Mulholland HG, Cantwell MM, Anderson LA, et al. Glycemic index, carbohydrate and fiber intakes and risk of reflux esophagitis, Barrett’s esophagus, and esophageal adenocarcinoma. Cancer Causes Control. 2009;20:279–88.PubMedCrossRef
10.
go back to reference Anderson LA, Watson RG, Murphy SJ, et al. Risk factors for Barrett’s oesophagus and oesophageal adenocarcinoma: results from the FINBAR study. World J Gastroenterol. 2007;13:1585–94.PubMed Anderson LA, Watson RG, Murphy SJ, et al. Risk factors for Barrett’s oesophagus and oesophageal adenocarcinoma: results from the FINBAR study. World J Gastroenterol. 2007;13:1585–94.PubMed
11.
go back to reference Day N, Oakes S, Luben R, et al. EPIC-Norfolk: study design and characteristics of the cohort. European Prospective Investigation of Cancer. Br J Cancer. 1999;80 Suppl 1:95–103.PubMed Day N, Oakes S, Luben R, et al. EPIC-Norfolk: study design and characteristics of the cohort. European Prospective Investigation of Cancer. Br J Cancer. 1999;80 Suppl 1:95–103.PubMed
12.
go back to reference Nejentsev S, Godfrey L, Snook H, et al. Comparative high-resolution analysis of linkage disequilibrium and tag single nucleotide polymorphisms between populations in the vitamin D receptor gene. Hum Mol Genet. 2004;13:1633–9.PubMedCrossRef Nejentsev S, Godfrey L, Snook H, et al. Comparative high-resolution analysis of linkage disequilibrium and tag single nucleotide polymorphisms between populations in the vitamin D receptor gene. Hum Mol Genet. 2004;13:1633–9.PubMedCrossRef
13.
go back to reference Slatter ML, Yakumo K, Hoffman M. Variants of the VDR gene and risk of colon cancer (United States). Cancer Causes Control. 2001;12:359–64.PubMedCrossRef Slatter ML, Yakumo K, Hoffman M. Variants of the VDR gene and risk of colon cancer (United States). Cancer Causes Control. 2001;12:359–64.PubMedCrossRef
14.
go back to reference Wigginton JE, Cutler DJ, Abecasis GR. A note on exact tests of Hardy–Weinberg equilibrium. Am J Hum Genet. 2005;76:887–93.PubMedCrossRef Wigginton JE, Cutler DJ, Abecasis GR. A note on exact tests of Hardy–Weinberg equilibrium. Am J Hum Genet. 2005;76:887–93.PubMedCrossRef
15.
go back to reference Whitfield GK, Remus LS, Jurutka PW, et al. Functionally relevant polymorphisms in the human nuclear vitamin D receptor gene. Mol Cell Endocrinol. 2001;177:145–59.PubMedCrossRef Whitfield GK, Remus LS, Jurutka PW, et al. Functionally relevant polymorphisms in the human nuclear vitamin D receptor gene. Mol Cell Endocrinol. 2001;177:145–59.PubMedCrossRef
16.
go back to reference Barrett JC, Fry B, Maller J, et al. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005;21:263–5.PubMedCrossRef Barrett JC, Fry B, Maller J, et al. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005;21:263–5.PubMedCrossRef
17.
go back to reference Li D, Diao Y, Li H, et al. Association of the polymorphisms of MTHFR C677T, VDR C352T, and MPO G463A with risk for esophageal squamous dysplasia and carcinoma. Arch Med Res. 2008;39:594–600.PubMedCrossRef Li D, Diao Y, Li H, et al. Association of the polymorphisms of MTHFR C677T, VDR C352T, and MPO G463A with risk for esophageal squamous dysplasia and carcinoma. Arch Med Res. 2008;39:594–600.PubMedCrossRef
18.
go back to reference Mulholland HG, Murray LJ, Anderson LA, et al. Vitamin D, calcium and dairy intake and risk of oesophageal adenocarcinoma and its pre-cursor conditions. Br J Nutr. 2011;011(9):1–10. Mulholland HG, Murray LJ, Anderson LA, et al. Vitamin D, calcium and dairy intake and risk of oesophageal adenocarcinoma and its pre-cursor conditions. Br J Nutr. 2011;011(9):1–10.
19.
go back to reference Köstner K, Denzer N, Müller CS, et al. The relevance of vitamin D receptor (VDR) gene polymorphisms for cancer: a review of the literature. Anticancer Res. 2009;29:3511–36.PubMed Köstner K, Denzer N, Müller CS, et al. The relevance of vitamin D receptor (VDR) gene polymorphisms for cancer: a review of the literature. Anticancer Res. 2009;29:3511–36.PubMed
Metadata
Title
Vitamin D Receptor Gene Variants and Esophageal Adenocarcinoma Risk: A Population-Based Case–Control Study
Authors
C. K. Chang
H. G. Mulholland
M. M. Cantwell
L. A. Anderson
B. T. Johnston
A. J. McKnight
P. D. Thompson
R. G. P. Watson
L. J. Murray
on behalf of the FINBAR study group
Publication date
01-09-2012
Publisher
Springer US
Published in
Journal of Gastrointestinal Cancer / Issue 3/2012
Print ISSN: 1941-6628
Electronic ISSN: 1941-6636
DOI
https://doi.org/10.1007/s12029-011-9322-9

Other articles of this Issue 3/2012

Journal of Gastrointestinal Cancer 3/2012 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.